A Multicenter, Double-blind, Non-inferiority, Phase 3 RCT Comparing GenSci094 and Recombinant FSH During the First Seven Days of Ovarian Stimulation in Chinese ART Patients
Latest Information Update: 06 Dec 2024
At a glance
- Drugs GenSci 094 (Primary) ; Chorionic gonadotropin; Follitropin alfa; Ganirelix; Progesterone
- Indications Female infertility
- Focus Registrational; Therapeutic Use
- Acronyms ANGAS
- Sponsors GeneScience Pharmaceuticals
- 03 Dec 2024 Status changed from recruiting to completed.
- 27 Oct 2023 New trial record